Sciwind Biosciences
PrivateLast Round
IPO Announced
Mar 23, 2026
Total Funding Raised
$136.5M
Momentum Score
75 /100
Company Overview
Sciwind Biosciences is a biopharmaceutical company focused on developing innovative drugs for the treatment of metabolic disorders, including diabetes, obesity, and non-alcoholic steatohepatitis, utilizing small molecules, proteins, and peptide candidates to improve therapeutic outcomes for patients.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Sciwind Biosciences Comps
Public and private peers based on sector, stage, and business model.
Sciwind Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| IPO Announced | Mar 23, 2026 | ||||
| Growth Equity | Jan 10, 2025 | ||||
| Series C | Oct 12, 2021 | ||||
| Series B | Feb 18, 2021 | ||||
| Series A | Feb 13, 2019 |
Sciwind Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Loyal Valley Capital | Series C |
| Oriza Holdings | Series B |
| Kaitai Capital | Series B |
| China International Capital Corporation | IPO |
| IDG Capital | Series C |
| LYFE Capital | Series C, Series B |
| Legend Capital | Series C, Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 17, 2026
Grew 43% QoQ from 7 to 10 employees.
- Apr 3, 2026
Developing core technology for siRNA, cyclic peptides, and oral peptides.
Sciwind Biosciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Sciwind Biosciences's valuation, stock price, and market status.
